Coronary disease & ACS

Prognostic Value of Cardiac Magnetic Resonance Imaging in Patients With a Working Diagnosis of MINOCA—An Outcome Study With up to 10 Years of Follow-Up

Circ Cardiovasc ImagingPublished Prospective registry cohort study

Authors' conclusion

In patients with a working diagnosis of MINOCA, CMR allows ruling-out true MINOCA in over half of the patients. CMR diagnoses of AMI, myocarditis, and NICM are associated with worse MACE-free survival, whereas a normal CMR study portends a benign prognosis.

Study context

Population
Consecutive patients with a working diagnosis of MINOCA clinically referred for cardiac magnetic resonance (CMR), academic hospital, October 2003–February 2020
Participants
252 patients
Exposure
CMR diagnosis categories vs normal CMR
  • Acute myocardial infarction (AMI)n = 63
  • Myocarditisn = 33
  • Nonischemic cardiomyopathy (NICM)n = 111
  • Normal CMRn = 37reference
  • Other diagnosesn = 8
Outcome
MACE
Follow-up
Up to 10 years
Methodological detailsconsecutive patients, single academic hospital
  • Consecutive patients
  • Single academic hospital

Main finding

As reported in the abstract

Unadjusted cumulative 10-year MACE rate
Difference across CMR diagnoses (log-rank)
P < 0.001
Incremental prognostic value of CMR diagnosis over clinical factors (incremental χ²)
17.9, P<0.001

Observational data: associations, not effects.

Further findings

True MINOCA ruled out by specific nonischemic cause

Proportion of cohort
57%

Overall MACE and deaths during follow-up (1595 patient-years) · up to 10 years

MACE
84 patients (33%)
Deaths
64 (25%)

Original publication

Prognostic Value of Cardiac Magnetic Resonance Imaging in Patients With a Working Diagnosis of MINOCA—An Outcome Study With up to 10 Years of Follow-Up. Circ Cardiovasc Imaging. Published 15 August 2023. doi:10.1161/circimaging.122.014454

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.